Recommended Topic Related To:

Nystatin and Triamcinolone Acetonide

"Spring break is on the way, or maybe summer vacation. Time to pack your swim suit, hit the beach, and perhaps indulge in a little harmless fun. What about getting a temporary tattoo to mark the occasion? Who could it hurt to get a temporary tatto"...

Nystatin and Triamcinolone Acetonide

Indications
Dosage
How Supplied

INDICATIONS

Nystatin and Triamcinolone Acetonide (nystatin and triamcinolone acetonide cream, ointment) Cream and Ointment are indicated for the treatment of cutaneous candidiasis; it has been demonstrated that the nystatin-steroid combination provides greater benefit than the nystatin component alone during the first few days of treatment.

DOSAGE AND ADMINISTRATION

Nystatin and Triamcinolone Acetonide (nystatin and triamcinolone acetonide cream, ointment) Cream is usually applied to the affected areas twice daily in the morning and evening by gently and thoroughly massaging the preparation into the skin. The cream should be discontinued if symptoms persist after 25 days of therapy (see PRECAUTIONS, Laboratory Tests).

Nystatin and Triamcinolone Acetonide (nystatin and triamcinolone acetonide cream, ointment) Cream and Ointment should not be used with occlusive dressings.

A thin film of Nystatin and Triamcinolone Acetonide (nystatin and triamcinolone acetonide cream, ointment) Ointment is usually applied to the affected areas twice daily in the morning and evening. The preparation should be discontinued if symptoms persist after 25 days of therapy (see PRECAUTIONS, Laboratory Tests).

HOW SUPPLIED

Nystatin and Triamcinolone Acetonide (nystatin and triamcinolone acetonide cream, ointment) Cream is supplied in 15 g, 30 g, and 60 g tubes. Nystatin and Triamcinolone Acetonide (nystatin and triamcinolone acetonide cream, ointment) Ointment is supplied in 15 g and 60 g tubes.

Storage: Store at controlled room temperature 15°-30°C (59°-86°F). Avoid freezing.

Caution: Federal law prohibits dispensing without a prescription.

Mfd. by: TARO Pharmaceuticals Inc., Bramalea, Ontario, Canada L6T 1C3 Revised March 1994. FDA Rev date: 07/05/01

Last reviewed on RxList: 8/11/2008
This monograph has been modified to include the generic and brand name in many instances.

Indications
Dosage
How Supplied
A A A

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.


From WebMD